Publications by Øystein Fodstad
331 publications found
Original articles
The expression pattern of pyruvate dehydrogenase kinases predicts prognosis and correlates with immune exhaustion in clear cell renal cell carcinoma
Sci Rep, 13 (1), 7339
DOI 10.1038/s41598-023-34087-x, PubMed 37147361
Correlation of expression of Major Vault Protein with androgen receptor and immune checkpoint protein B7-H3, and with poor prognosis in prostate cancer
Pathol Res Pract, 241, 154243
DOI 10.1016/j.prp.2022.154243, PubMed 36481650
Heterogeneous Expression and Subcellular Localization of Pyruvate Dehydrogenase Complex in Prostate Cancer
Front Oncol, 12, 873516
DOI 10.3389/fonc.2022.873516, PubMed 35692804
Novel human melanoma brain metastasis models in athymic nude fox1nu mice: Site-specific metastasis patterns reflecting their clinical origin
Cancer Med, 10 (23), 8604-8613
DOI 10.1002/cam4.4334, PubMed 34612023
Immune checkpoint B7-H3 protein expression is associated with poor outcome and androgen receptor status in prostate cancer
Prostate, 81 (12), 838-848
DOI 10.1002/pros.24180, PubMed 34125445
Increased Local Inflammatory Response to MOC31PE Immunotoxin After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Ann Surg Oncol, 28 (9), 5252-5262
DOI 10.1245/s10434-021-10022-0, PubMed 34019185
Cytoplasmic expression of B7-H3 and membranous EpCAM expression are associated with higher grade and survival outcomes in patients with clear cell renal cell carcinoma
Ann Diagn Pathol, 46, 151483
DOI 10.1016/j.anndiagpath.2020.151483, PubMed 32143173
Immune stimulatory effect of anti-EpCAM immunotoxin - improved overall survival of metastatic colorectal cancer patients
Acta Oncol, 59 (4), 404-409
DOI 10.1080/0284186X.2019.1704864, PubMed 31876430
Spheroid-Derived Cells From Renal Adenocarcinoma Have Low Telomerase Activity and High Stem-Like and Invasive Characteristics
Front Oncol, 9, 1302
DOI 10.3389/fonc.2019.01302, PubMed 31921617
ImmunoPeCa trial: Long-term outcome following intraperitoneal MOC31PE immunotoxin treatment in colorectal peritoneal metastasis
Eur J Surg Oncol, 47 (1), 134-138
DOI 10.1016/j.ejso.2019.04.014, PubMed 31036394
p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance
Sci Rep, 9 (1), 5839
DOI 10.1038/s41598-019-42303-w, PubMed 30967582
Human telomerase reverse transcriptase protein expression predicts tumour aggressiveness and survival in patients with clear cell renal cell carcinoma
Pathology, 51 (1), 21-31
DOI 10.1016/j.pathol.2018.08.019, PubMed 30466948
Increased expression of CD44 is associated with more aggressive behavior in clear cell renal cell carcinoma
Biomark Med, 12 (1), 45-61
DOI 10.2217/bmm-2017-0142, PubMed 29243496
The Results of Stricter Inclusion Criteria in an Immunomagnetic Detection Study of Micrometastatic Cells in Bone Marrow of Uveal Melanoma Patients - Relevance for Dormancy
Pathol Oncol Res, 25 (1), 255-262
DOI 10.1007/s12253-017-0355-7, PubMed 29098521
Immunoregulatory protein B7-H3 promotes growth and decreases sensitivity to therapy in metastatic melanoma cells
Pigment Cell Melanoma Res, 30 (5), 467-476
DOI 10.1111/pcmr.12599, PubMed 28513992
MOC31PE immunotoxin - targeting peritoneal metastasis from epithelial ovarian cancer
Oncotarget, 8 (37), 61800-61809
DOI 10.18632/oncotarget.18694, PubMed 28977905
Novel Treatment with Intraperitoneal MOC31PE Immunotoxin in Colorectal Peritoneal Metastasis: Results From the ImmunoPeCa Phase 1 Trial
Ann Surg Oncol, 24 (7), 1916-1922
DOI 10.1245/s10434-017-5814-6, PubMed 28224367
A novel rat fibrosarcoma cell line from transformed bone marrow-derived mesenchymal stem cells with maintained in vitro and in vivo stemness properties
Exp Cell Res, 352 (2), 218-224
DOI 10.1016/j.yexcr.2017.02.005, PubMed 28189639
Detection of disseminated tumor cells in lymph nodes from patients with early stage non-small cell lung cancer
Diagn Pathol, 11 (1), 50
DOI 10.1186/s13000-016-0504-4, PubMed 27316334
Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α
Cancer Res, 76 (8), 2231-42
DOI 10.1158/0008-5472.CAN-15-1538, PubMed 27197253
Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitors
Oncotarget, 7 (6), 6891-901
DOI 10.18632/oncotarget.6902, PubMed 26771843
Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporin
Br J Cancer, 113 (11), 1548-55
DOI 10.1038/bjc.2015.380, PubMed 26554649
Tumour exosome integrins determine organotropic metastasis
Nature, 527 (7578), 329-35
DOI 10.1038/nature15756, PubMed 26524530
Bilateral uveal melanomas with different gene expression detected with 7 years interval
Acta Ophthalmol, 94 (1), 99-102
DOI 10.1111/aos.12857, PubMed 26496992
Interleukin-8 is a key mediator of FKBP51-induced melanoma growth, angiogenesis and metastasis
Br J Cancer, 112 (11), 1772-81
DOI 10.1038/bjc.2015.154, PubMed 25942396
Immunomagnetic detection of micrometastatic cells in bone marrow of uveal melanoma patients: a paradox
Acta Ophthalmol, 93 (1), 59-66
DOI 10.1111/aos.12462, PubMed 25613126
B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome
BMC Cancer, 14, 602
DOI 10.1186/1471-2407-14-602, PubMed 25139714
Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c
Br J Cancer, 110 (8), 2072-80
DOI 10.1038/bjc.2014.113, PubMed 24577056
The MOC31PE immunotoxin reduces cell migration and induces gene expression and cell death in ovarian cancer cells
J Ovarian Res, 7, 23
DOI 10.1186/1757-2215-7-23, PubMed 24528603
Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer
Clin Colorectal Cancer, 12 (4), 261-6
DOI 10.1016/j.clcc.2013.06.003, PubMed 24012455
Antitumor activity of elacytarabine combined with bevacizumab, cetuximab and trastuzumab in human NSCLC xenografts
Anticancer Res, 33 (9), 3615-21
PubMed 24023287
Clinical significance of disseminated tumour cells in non-small cell lung cancer
Br J Cancer, 109 (5), 1264-70
DOI 10.1038/bjc.2013.450, PubMed 23942067
In vitro and in vivo properties of CD133 expressing cells from human lung cancer cell lines
Exp Hematol Oncol, 2 (1), 16
DOI 10.1186/2162-3619-2-16, PubMed 23738757
Immunotoxin targeting EpCAM effectively inhibits peritoneal tumor growth in experimental models of mucinous peritoneal surface malignancies
Int J Cancer, 133 (6), 1497-506
DOI 10.1002/ijc.28158, PubMed 23494569
Heat shock factor 1 (HSF1) controls chemoresistance and autophagy through transcriptional regulation of autophagy-related protein 7 (ATG7)
J Biol Chem, 288 (13), 9165-76
DOI 10.1074/jbc.M112.422071, PubMed 23386620
Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer
PLoS One, 8 (6), e66165
DOI 10.1371/journal.pone.0066165, PubMed 23824282
miR-125b functions as a key mediator for snail-induced stem cell propagation and chemoresistance
J Biol Chem, 288 (6), 4334-45
DOI 10.1074/jbc.M112.419168, PubMed 23255607
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
BMC Cancer, 12, 505
DOI 10.1186/1471-2407-12-505, PubMed 23121918
Cytoplasmic translocation of p21 mediates NUPR1-induced chemoresistance: NUPR1 and p21 in chemoresistance
FEBS Lett, 586 (19), 3429-34
DOI 10.1016/j.febslet.2012.07.063, PubMed 22858377
Disseminated tumour cells in bone marrow of patients with uveal melanoma
Acta Ophthalmol, 91 (4), 343-8
DOI 10.1111/j.1755-3768.2012.02449.x, PubMed 22632270
B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer
Int J Cancer, 131 (11), 2528-36
DOI 10.1002/ijc.27566, PubMed 22473715
Receptor tyrosine kinase ErbB2 translocates into mitochondria and regulates cellular metabolism
Nat Commun, 3, 1271
DOI 10.1038/ncomms2236, PubMed 23232401
Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma
BMC Cancer, 11, 455
DOI 10.1186/1471-2407-11-455, PubMed 22014070
Tumor kinase activity in locally advanced rectal cancer: angiogenic signaling and early systemic dissemination
Angiogenesis, 14 (4), 481-9
DOI 10.1007/s10456-011-9231-3, PubMed 21833622
B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes
Int J Cancer, 130 (10), 2282-90
DOI 10.1002/ijc.26238, PubMed 21671471
Analysis of EpCAM positive cells isolated from sentinel lymph nodes of breast cancer patients identifies subpopulations of cells with distinct transcription profiles
Breast Cancer Res, 13 (4), R75
DOI 10.1186/bcr2922, PubMed 21816090
Triphenylmethyl derivatives enhances the anticancer effect of immunotoxins
J Immunother, 34 (5), 438-47
DOI 10.1097/CJI.0b013e31821e00ae, PubMed 21577141
B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation
Mol Cancer Ther, 10 (6), 960-71
DOI 10.1158/1535-7163.MCT-11-0072, PubMed 21518725
Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism
Cancer Res, 71 (13), 4585-97
DOI 10.1158/0008-5472.CAN-11-0127, PubMed 21498634
Disseminated tumour cells as a prognostic biomarker in colorectal cancer
Br J Cancer, 104 (9), 1434-9
DOI 10.1038/bjc.2011.97, PubMed 21448171
Antitumour activity of oral E7080, a novel inhibitor of multiple tyrosine kinases, in human sarcoma xenografts
Int J Cancer, 129 (3), 742-50
DOI 10.1002/ijc.25922, PubMed 21225632
Systematic evaluation of three microRNA profiling platforms: microarray, beads array, and quantitative real-time PCR array
PLoS One, 6 (2), e17167
DOI 10.1371/journal.pone.0017167, PubMed 21347261
Emerging metabolic targets in cancer therapy
Front Biosci (Landmark Ed), 16 (5), 1844-60
DOI 10.2741/3826, PubMed 21196269
Synergistic anticancer effects of the 9.2.27PE immunotoxin and ABT-737 in melanoma
PLoS One, 6 (9), e24012
DOI 10.1371/journal.pone.0024012, PubMed 21915275
A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth
Cancer Immunol Immunother, 59 (11), 1665-74
DOI 10.1007/s00262-010-0892-3, PubMed 20635083
MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression
J Biol Chem, 285 (28), 21496-507
DOI 10.1074/jbc.M109.083337, PubMed 20460378
Anti-melanoma activity of the 9.2.27PE immunotoxin in dacarbazine resistant cells
J Immunother, 33 (3), 272-8
DOI 10.1097/CJI.0b013e3181c54991, PubMed 20445347
Primary gene-engineered neural stem/progenitor cells demonstrate tumor-selective migration and antitumor effects in glioma
Int J Cancer, 126 (5), 1206-15
DOI 10.1002/ijc.24809, PubMed 19653275
Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol
Mol Cancer, 9, 33
DOI 10.1186/1476-4598-9-33, PubMed 20144215
Cystatin E/M suppresses legumain activity and invasion of human melanoma
BMC Cancer, 10, 17
DOI 10.1186/1471-2407-10-17, PubMed 20074384
Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models
Invest New Drugs, 29 (3), 456-66
DOI 10.1007/s10637-009-9377-7, PubMed 20066470
The transcript expression and protein distribution pattern in human colorectal carcinoma reveal a pivotal role of COM-1/p8 as a tumour suppressor
Cancer Genomics Proteomics, 7 (2), 75-80
PubMed 20335521
Immunotoxins: a promising treatment modality for metastatic melanoma?
Ochsner J, 10 (3), 193-9
PubMed 21603377
Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1
Oncology, 78 (1), 75-86
DOI 10.1159/000292363, PubMed 20215788
Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide
Clin Cancer Res, 15 (23), 7161-9
DOI 10.1158/1078-0432.CCR-08-2816, PubMed 19920113
Immunomagnetic detection of micrometastatic cells in bone marrow in uveal melanoma patients
Acta Ophthalmol, 87 (8), 830-6
DOI 10.1111/j.1755-3768.2008.01378.x, PubMed 19055657
Functional characterization of the progestagen-associated endometrial protein gene in human melanoma
J Cell Mol Med, 14 (6B), 1432-42
DOI 10.1111/j.1582-4934.2009.00922.x, PubMed 19799645
Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo
Br J Cancer, 101 (8), 1307-15
DOI 10.1038/sj.bjc.6605312, PubMed 19773757
Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells
Oncogene, 28 (46), 4065-74
DOI 10.1038/onc.2009.274, PubMed 19734943
Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth
Oncogene, 28 (42), 3689-701
DOI 10.1038/onc.2009.229, PubMed 19668225
Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models
Mol Oncol, 3 (5-6), 469-82
DOI 10.1016/j.molonc.2009.07.003, PubMed 19713161
The melanoma specific 9.2.27PE immunotoxin efficiently kills melanoma cells in vitro
Int J Cancer, 125 (1), 23-33
DOI 10.1002/ijc.24317, PubMed 19350633
The 14-3-3sigma gene promoter is methylated in both human melanocytes and melanoma
BMC Cancer, 9, 162
DOI 10.1186/1471-2407-9-162, PubMed 19473536
Osteoblast-induced EGFR/ERBB2 signaling in androgen-sensitive prostate carcinoma cells characterized by multiplex kinase activity profiling
Clin Exp Metastasis, 26 (5), 485-96
DOI 10.1007/s10585-009-9248-9, PubMed 19294521
Bone marrow micrometastases studied by an immunomagnetic isolation procedure in extremity localized non-metastatic osteosarcoma patients
Cancer Treat Res, 152, 509-15
DOI 10.1007/978-1-4419-0284-9_30, PubMed 20213412
Expression and functional analysis of the WAP four disulfide core domain 1 gene in human melanoma
Clin Exp Metastasis, 26 (7), 739-49
DOI 10.1007/s10585-009-9273-8, PubMed 19488830
Inhibition of in vivo tumour growth by the blocking of host alpha(v)beta3 and alphaII(b)beta3 integrins
Anticancer Res, 29 (1), 131-7
PubMed 19331142
The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma
Stem Cells, 26 (12), 3008-17
DOI 10.1634/stemcells.2008-0601, PubMed 18802032
The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis
BMC Med Genomics, 1, 13
DOI 10.1186/1755-8794-1-13, PubMed 18442402
Primary neural stem/progenitor cells expressing endostatin or cytochrome P450 for gene therapy of glioblastoma
Cancer Gene Ther, 15 (9), 605-15
DOI 10.1038/cgt.2008.23, PubMed 18421309
S100B in bone marrow aspirates in healthy individuals and malignant melanoma patients
Melanoma Res, 18 (2), 134-40
DOI 10.1097/CMR.0b013e3282f623d9, PubMed 18337650
Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets
Exp Cell Res, 314 (10), 2110-22
DOI 10.1016/j.yexcr.2008.03.008, PubMed 18423605
Bone marrow micrometastases in advanced stage non-small cell lung carcinoma patients
Lung Cancer, 61 (2), 170-6
DOI 10.1016/j.lungcan.2007.12.018, PubMed 18261824
CDH11 expression is associated with survival in patients with osteosarcoma
Cancer Genomics Proteomics, 5 (1), 37-42
PubMed 18359978
Global comparative gene expression analysis of melanoma patient samples, derived cell lines and corresponding tumor xenografts
Cancer Genomics Proteomics, 5 (1), 1-35
PubMed 18359977
Rac1 activity regulates proliferation of aggressive metastatic melanoma
Exp Cell Res, 313 (18), 3832-9
DOI 10.1016/j.yexcr.2007.08.017, PubMed 17904119
Pseudomyxoma peritonei--two novel orthotopic mouse models portray the PMCA-I histopathologic subtype
BMC Cancer, 7, 116
DOI 10.1186/1471-2407-7-116, PubMed 17603904
[The 75th anniversary of the Radium Hospital]
Tidsskr Nor Laegeforen, 127 (13), 1800-1
PubMed 17599133
Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling
Pigment Cell Melanoma Res, 21 (5), 545-58
DOI 10.1111/j.1755-148X.2008.00484.x, PubMed 18627528
Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines
J Gene Med, 9 (6), 440-51
DOI 10.1002/jgm.1036, PubMed 17410615
Gamma-glutamylcysteine synthetase-based selection strategy for gene therapy of chronic granulomatous disease and graft-vs.-host disease
Eur J Haematol, 78 (5), 440-8
DOI 10.1111/j.1600-0609.2007.00833.x, PubMed 17331133
Clinically proven markers of metastasis predict metastatic spread of human melanoma cells engrafted in scid mice
Br J Cancer, 96 (4), 609-16
DOI 10.1038/sj.bjc.6603594, PubMed 17262079
Specific isolation of disseminated cancer cells: a new method permitting sensitive detection of target molecules of diagnostic and therapeutic value
Clin Exp Metastasis, 24 (5), 317-27
DOI 10.1007/s10585-006-9052-8, PubMed 17530423
Does the PGC-1/PPARgamma pathway play a role in Com-1/p8 mediated cell growth inhibition in prostate cancer?
Int J Mol Med, 18 (6), 1169-75
PubMed 17089023
Association of insulin-like growth factor binding protein-3 expression with melanoma progression
Mol Cancer Ther, 5 (12), 3078-84
DOI 10.1158/1535-7163.MCT-06-0424, PubMed 17172410
Com-1/p8 acts as a putative tumour suppressor in prostate cancer
Int J Mol Med, 18 (5), 981-6
PubMed 17016631
Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition
Radiat Oncol, 1, 25
DOI 10.1186/1748-717X-1-25, PubMed 16887021
AMP-activated protein kinase protects against anti-epidermal growth factor receptor-Pseudomonas exotoxin A immunotoxin-induced MA11 breast cancer cell death
Mol Cancer Ther, 5 (4), 1050-9
DOI 10.1158/1535-7163.MCT-05-0318, PubMed 16648577
Secretory protein enrichment and analysis: an optimized approach applied on cancer cell lines using 2D LC-MS/MS
J Proteome Res, 5 (4), 899-906
DOI 10.1021/pr050375p, PubMed 16602697
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer
Clin Cancer Res, 12 (7 Pt 1), 2014-24
DOI 10.1158/1078-0432.CCR-05-1853, PubMed 16609010
DNA damage responses in cell cycle G2 phase and mitosis--tracking and targeting
Anticancer Res, 26 (3A), 1909-16
PubMed 16827124
Expression of Com-1/P8 in human breast cancer and its relevance to clinical outcome and ER status
Int J Cancer, 117 (5), 730-7
DOI 10.1002/ijc.21221, PubMed 15957166
Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers
Cancer Gene Ther, 12 (11), 864-72
DOI 10.1038/sj.cgt.7700852, PubMed 15891771
Cell cycle checkpoint signaling involved in histone deacetylase inhibition and radiation-induced cell death
Mol Cancer Ther, 4 (8), 1231-8
DOI 10.1158/1535-7163.MCT-04-0304, PubMed 16093439
Hematogenous micrometastases in osteosarcoma patients
Clin Cancer Res, 11 (13), 4666-73
DOI 10.1158/1078-0432.CCR-05-0165, PubMed 16000559
Gamma-glutamylcysteine synthetase and L-buthionine-(S,R)-sulfoximine: a new selection strategy for gene-transduced neural and hematopoietic stem/progenitor cells
Hum Gene Ther, 16 (6), 711-24
DOI 10.1089/hum.2005.16.711, PubMed 15960602
Garlic arrests MDA-MB-435 cancer cells in mitosis, phosphorylates the proapoptotic BH3-only protein BimEL and induces apoptosis
Br J Cancer, 92 (9), 1773-81
DOI 10.1038/sj.bjc.6602537, PubMed 15827557
PCI-enhanced adenoviral transduction employs the known uptake mechanism of adenoviral particles
Cancer Gene Ther, 12 (5), 439-48
DOI 10.1038/sj.cgt.7700808, PubMed 15678152
Com-1/P8 in oestrogen regulated growth of breast cancer cells, the ER-beta connection
Biochem Biophys Res Commun, 330 (1), 253-62
DOI 10.1016/j.bbrc.2005.02.157, PubMed 15781258
Matrix metalloproteinases participate in osteosarcoma invasion
J Surg Res, 127 (2), 151-6
DOI 10.1016/j.jss.2004.12.016, PubMed 16083752
Downregulation of tissue factor by RNA interference in human melanoma LOX-L cells reduces pulmonary metastasis in nude mice
Int J Cancer, 112 (6), 994-1002
DOI 10.1002/ijc.20527, PubMed 15386437
Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer
Endocr Relat Cancer, 11 (4), 781-91
DOI 10.1677/erc.1.00825, PubMed 15613452
Downregulation of the antiapoptotic MCL-1 protein and apoptosis in MA-11 breast cancer cells induced by an anti-epidermal growth factor receptor-Pseudomonas exotoxin a immunotoxin
Int J Cancer, 112 (3), 475-83
DOI 10.1002/ijc.20371, PubMed 15382075
Antiproliferative activity and mechanism of action of fatty acid derivatives of gemcitabine in leukemia and solid tumor cell lines and in human xenografts
Nucleosides Nucleotides Nucleic Acids, 23 (8-9), 1329-33
DOI 10.1081/NCN-200027579, PubMed 15571253
Inhibitory targeting of checkpoint kinase signaling overrides radiation-induced cell cycle gene regulation: a therapeutic strategy in tumor cell radiosensitization?
Radiother Oncol, 72 (3), 305-10
DOI 10.1016/j.radonc.2004.07.002, PubMed 15450729
Sensitization of interferon-gamma induced apoptosis in human osteosarcoma cells by extracellular S100A4
BMC Cancer, 4, 52
DOI 10.1186/1471-2407-4-52, PubMed 15318945
Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma
Mod Pathol, 17 (8), 990-7
DOI 10.1038/modpathol.3800151, PubMed 15133476
Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice
Eur J Cancer, 40 (10), 1593-8
DOI 10.1016/j.ejca.2004.02.023, PubMed 15196545
Immunomagnetic detection and clinical significance of micrometastatic tumor cells in malignant melanoma patients
Clin Cancer Res, 10 (12 Pt 1), 4134-9
DOI 10.1158/1078-0432.CCR-03-0408, PubMed 15217950
Plasminogen activator inhibitor-1 increases the expression of VEGF in human glioma cells
Exp Cell Res, 294 (1), 130-9
DOI 10.1016/j.yexcr.2003.10.013, PubMed 14980508
Immunotoxin treatment targeted to the high-molecular-weight melanoma-associated antigen prolonging the survival of immunodeficient rats with invasive intracranial human glioblastoma multiforme
J Neurosurg, 100 (2), 320-7
DOI 10.3171/jns.2004.100.2.0320, PubMed 15086240
Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator
Breast Cancer Res, 6 (5), R478-87
DOI 10.1186/bcr815, PubMed 15318930
Immunofluorometric assay for the metastasis-related protein S100A4: release of S100A4 from normal blood cells prohibits the use of S100A4 as a tumor marker in plasma and serum
Tumour Biol, 25 (1-2), 31-40
DOI 10.1159/000077721, PubMed 15192310
Human osteosarcoma xenografts and their sensitivity to chemotherapy
Pathol Oncol Res, 10 (3), 133-41
DOI 10.1007/BF03033741, PubMed 15448748
Ionizing radiation inhibits the PLK cell cycle gene in a G2 checkpoint-dependent manner
Anticancer Res, 24 (2B), 555-62
PubMed 15160994
Efficient expansion and gene transduction of mouse neural stem/progenitor cells on recombinant fibronectin
Neuroscience, 124 (4), 823-30
DOI 10.1016/j.neuroscience.2003.11.030, PubMed 15026123
Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1
Oncogene, 22 (55), 8952-5
DOI 10.1038/sj.onc.1207000, PubMed 14654792
Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma
Clin Cancer Res, 9 (9), 3383-8
PubMed 12960126
Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer
J Pathol, 200 (5), 589-95
DOI 10.1002/path.1381, PubMed 12898594
Interferon-gamma suppresses S100A4 transcription independently of apoptosis or cell cycle arrest
Br J Cancer, 88 (12), 1995-2001
DOI 10.1038/sj.bjc.6600998, PubMed 12799648
Detection of disseminated tumour cells in bone marrow of patients with isolated liver metastases from colorectal cancer
J Surg Oncol, 82 (4), 224-7
DOI 10.1002/jso.10223, PubMed 12672004
Effects of mRNA amplification on gene expression ratios in cDNA experiments estimated by analysis of variance
BMC Genomics, 4 (1), 11
DOI 10.1186/1471-2164-4-11, PubMed 12659661
S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells
Clin Exp Metastasis, 20 (8), 701-11
DOI 10.1023/b:clin.0000006819.21361.03, PubMed 14713104
Retroviral transfer of MRP1 and gamma-glutamyl cysteine synthetase modulates cell sensitivity to L-buthionine-S,R-sulphoximine (BSO): new rationale for the use of BSO in cancer therapy
Eur J Cancer, 39 (1), 120-8
DOI 10.1016/s0959-8049(02)00447-1, PubMed 12504668
The metalloproteinase inhibitor TIMP-2 is down-regulated by androgens in LNCaP prostate carcinoma cells
Clin Exp Metastasis, 20 (6), 541-7
DOI 10.1023/a:1025860214891, PubMed 14598888
Modulation of glioma cell invasion and motility by adenoviral gene transfer of PAI-1
Clin Exp Metastasis, 20 (4), 301-9
DOI 10.1023/a:1024040718238, PubMed 12856717
Frequent promoter hypermethylation of the O6-Methylguanine-DNA Methyltransferase (MGMT) gene in testicular cancer
Oncogene, 21 (57), 8878-84
DOI 10.1038/sj.onc.1205978, PubMed 12483540
Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies
Br J Cancer, 87 (11), 1281-6
DOI 10.1038/sj.bjc.6600624, PubMed 12439718
Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model
Cancer Res, 62 (11), 3120-5
PubMed 12036923
Light-induced adenovirus gene transfer, an efficient and specific gene delivery technology for cancer gene therapy
Cancer Gene Ther, 9 (4), 365-71
DOI 10.1038/sj.cgt.7700447, PubMed 11960287
Role of the Multidrug Resistance Protein 1 in protection from heavy metal oxyanions: investigations in vitro and in MRP1-deficient mice
Biochem Biophys Res Commun, 291 (3), 617-22
DOI 10.1006/bbrc.2002.6489, PubMed 11855834
Role of the multidrug resistance protein 1 gene in the carcinogenicity of aflatoxin B1: investigations using mrp1-null mice
Toxicology, 171 (2-3), 201-5
DOI 10.1016/s0300-483x(01)00584-4, PubMed 11836025
Intratumoral immunotoxin treatment of human malignant brain tumors in immunodeficient animals
Int J Cancer, 97 (6), 846-52
DOI 10.1002/ijc.10137, PubMed 11857366
Circulating tumor cells in the peripheral blood and bone marrow of patients with ovarian carcinoma do not predict prognosis
Cancer, 94 (3), 707-12
DOI 10.1002/cncr.10250, PubMed 11857303
Immunomagnetic detection of micrometastatic cells in bone marrow of colorectal cancer patients
Clin Cancer Res, 8 (2), 444-9
PubMed 11839662
Differential display analysis of breast carcinoma cells enriched by immunomagnetic target cell selection: gene expression profiles in bone marrow target cells
Int J Cancer, 97 (1), 28-33
DOI 10.1002/ijc.1564, PubMed 11774240
Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastases
Anticancer Res, 22 (4), 1949-57
PubMed 12174869
Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas-a possible mechanism for altering the nm23-H1 activity
Oncogene, 20 (47), 6881-90
DOI 10.1038/sj.onc.1204874, PubMed 11687967
Novel bicistronic retroviral vector expressing gamma-glutamylcysteine synthetase and the multidrug resistance protein 1 (MRP1) protects cells from MRP1-effluxed drugs and alkylating agents
Hum Gene Ther, 12 (14), 1785-96
DOI 10.1089/104303401750476276, PubMed 11560771
Expression of matrix metalloproteinases and the metastasis-associated gene S100A4 in human neuroblastoma and primitive neuroectodermal tumor cells
J Pediatr Surg, 36 (7), 1040-4
DOI 10.1053/jpsu.2001.24735, PubMed 11431772
In vivo documentation of photochemical internalization, a novel approach to site specific cancer therapy
Int J Cancer, 92 (5), 761-6
DOI 10.1002/1097-0215(20010601)92:5<761::aid-ijc1238>3.0.co;2-4, PubMed 11340584
Expression of ring finger-deleted TRAF2 sensitizes metastatic melanoma cells to apoptosis via up-regulation of p38, TNFalpha and suppression of NF-kappaB activities
Oncogene, 20 (18), 2243-53
DOI 10.1038/sj.onc.1204314, PubMed 11402319
Optimization of hammerhead ribozymes for the cleavage of S100A4 (CAPL) mRNA
Antisense Nucleic Acid Drug Dev, 11 (2), 67-75
DOI 10.1089/108729001750171272, PubMed 11334142
Immunobead-based detection and characterization of circulating tumor cells in melanoma patients
Recent Results Cancer Res, 158, 40-50
DOI 10.1007/978-3-642-59537-0_5, PubMed 11092032
Rapid enrichment and detection of melanoma cells from peripheral blood mononuclear cells by a new assay combining immunomagnetic cell sorting and immunocytochemical staining
Recent Results Cancer Res, 158, 51-60
DOI 10.1007/978-3-642-59537-0_6, PubMed 11092033
Systemic immunotoxin treatment inhibits formation of human breast cancer metastasis and tumor growth in nude rats
Int J Cancer, 88 (6), 970-6
DOI 10.1002/1097-0215(20001215)88:6<970::aid-ijc21>3.0.co;2-q, PubMed 11093823
Expression of a novel factor, com1, is regulated by 1,25-dihydroxyvitamin D3 in breast cancer cells
Cancer Res, 60 (19), 5578-83
PubMed 11034106
Photochemical internalisation increases the cytotoxic effect of the immunotoxin MOC31-gelonin
Int J Cancer, 87 (6), 853-9
DOI 10.1002/1097-0215(20000915)87:6<853::aid-ijc15>3.0.co;2-0, PubMed 10956397
Expression of a novel factor, com1, in early tumor progression of breast cancer
Clin Cancer Res, 6 (5), 1778-83
PubMed 10815897
Structure-activity studies of novobiocin analogs as modulators of the cytotoxicity of etoposide (VP-16)
Oncol Res, 12 (3), 113-9
DOI 10.3727/096504001108747585, PubMed 11216669
S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme
Cancer Res, 59 (18), 4702-8
PubMed 10493528
Expression of a novel factor in human breast cancer cells with metastatic potential
Cancer Res, 59 (18), 4675-80
PubMed 10493524
Site-specific experimental metastasis patterns of two human breast cancer cell lines in nude rats
Int J Cancer, 82 (2), 219-25
DOI 10.1002/(sici)1097-0215(19990719)82:2<219::aid-ijc12>3.0.co;2-#, PubMed 10389756
Superior therapeutic efficacy of N-L-leucyl-doxorubicin versus doxorubicin in human melanoma xenografts correlates with higher tumour concentrations of free drug
Eur J Cancer, 35 (7), 1143-9
DOI 10.1016/s0959-8049(99)00074-x, PubMed 10533461
Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft models
Cancer Res, 59 (12), 2944-9
PubMed 10383159
Sensitive fluorescent in situ hybridisation method for the characterisation of breast cancer cells in bone marrow aspirates
Mol Pathol, 52 (2), 68-74
DOI 10.1136/mp.52.2.68, PubMed 10474684
Photochemical internalization: a novel technology for delivery of macromolecules into cytosol
Cancer Res, 59 (6), 1180-3
PubMed 10096543
Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells
Int J Cancer, 80 (1), 119-25
DOI 10.1002/(sici)1097-0215(19990105)80:1<119::aid-ijc22>3.0.co;2-x, PubMed 9935241
Growth of precultured human glioma specimens in nude rat brain
J Neurosurg, 90 (1), 125-32
DOI 10.3171/jns.1999.90.1.0125, PubMed 10413165
Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells
Cytotherapy, 1 (5), 377-88
DOI 10.1080/0032472031000141283, PubMed 20426539
Intracellular metabolism of a 2'-O-methyl-stabilized ribozyme after uptake by DOTAP transfection or asfree ribozyme. A study by capillary electrophoresis
Nucleic Acids Res, 26 (18), 4241-8
DOI 10.1093/nar/26.18.4241, PubMed 9722645
The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts
Eur J Cancer, 34 (10), 1602-6
DOI 10.1016/s0959-8049(98)00152-x, PubMed 9893636
Molecular characterization of a novel amplicon at 1q21-q22 frequently observed in human sarcomas
Br J Cancer, 78 (4), 495-503
DOI 10.1038/bjc.1998.521, PubMed 9716033
Regulation of tissue-degrading factors and in vitro invasiveness in progression of breast cancer cells
Clin Exp Metastasis, 16 (3), 205-15
DOI 10.1023/a:1006584624061, PubMed 9568638
Invasion potential and N-acetylgalactosamine expression in a human melanoma model
Int J Cancer, 75 (4), 609-14
DOI 10.1002/(sici)1097-0215(19980209)75:4<609::aid-ijc19>3.0.co;2-3, PubMed 9466664
Human hepatoma cells rich in P-glycoprotein display enhanced in vitro invasive properties compared to P-glycoprotein-poor hepatoma cells
Oncol Res, 10 (5), 255-62
PubMed 9802060
Interleukin-1 alpha and basic fibroblast growth factor induction of matrix metalloproteinases and their inhibitors in osteosarcoma cells is modulated by the metastasis associated protein CAPL
Anticancer Res, 18 (5A), 3299-303
PubMed 9858899
High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases
Clin Cancer Res, 3 (9), 1623-8
PubMed 9815852
Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma
Int J Cancer, 74 (4), 464-9
DOI 10.1002/(sici)1097-0215(19970822)74:4<464::aid-ijc19>3.0.co;2-9, PubMed 9291441
Ectopic expression of target genes may represent an inherent limitation of RT-PCR assays used for micrometastasis detection: studies on the epithelial glycoprotein gene EGP-2
Int J Cancer, 72 (1), 191-6
DOI 10.1002/(sici)1097-0215(19970703)72:1<191::aid-ijc27>3.0.co;2-l, PubMed 9212242
HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas
Oncogene, 14 (24), 2935-41
DOI 10.1038/sj.onc.1201135, PubMed 9205100
Molecular cytogenetics of bone and soft tissue tumors
Cancer Genet Cytogenet, 95 (1), 67-73
DOI 10.1016/s0165-4608(96)00241-5, PubMed 9140455
Zilascorb(2H), a new reversible protein synthesis inhibitor: clinical study of an oral preparation
Anticancer Drugs, 8 (3), 296-303
DOI 10.1097/00001813-199703000-00013, PubMed 9095337
Immunobead filtration: a novel approach for the isolation and propagation of tumor cells
Am J Pathol, 150 (1), 99-106
PubMed 9006327
Cyclin kinase inhibitor p21WAF1/CIP1 in malignant melanoma: reduced expression in metastatic lesions
Am J Pathol, 149 (6), 1813-22
PubMed 8952518
Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme
Cancer Res, 56 (23), 5490-8
PubMed 8968106
Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas
Genes Chromosomes Cancer, 17 (4), 254-9
DOI 10.1002/(SICI)1098-2264(199612)17:4<254::AID-GCC7>3.0.CO;2-2, PubMed 8946207
Brain metastasis model in athymic nude mice using a novel MUC1-secreting human breast-cancer cell line, MA11
Int J Cancer, 68 (5), 682-7
DOI 10.1002/(SICI)1097-0215(19961127)68:5<682::AID-IJC20>3.0.CO;2-2, PubMed 8938153
Regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in MCF-7 cells: comparison with regulatory mechanisms of pS2 expression
Clin Exp Metastasis, 14 (4), 381-8
DOI 10.1007/BF00123397, PubMed 8878412
Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas
Br J Cancer, 73 (8), 909-16
DOI 10.1038/bjc.1996.181, PubMed 8611425
Comparative antitumor activities of halichondrins and vinblastine against human tumor xenografts
J Exp Ther Oncol, 1 (2), 119-25
PubMed 9414395
Cysteine proteinase inhibitors reduce malignant melanoma cell invasion in vitro
Anticancer Res, 16 (4A), 1627-31
PubMed 8712680
Breast cancer-associated antibody LU BCRU G7 recognises the terminal disaccharide Gal beta 1-3GlcNAc and can be used to isolate tumour cells from body fluids by an immunomagnetic bead procedure
Biochem Soc Trans, 23 (4), 584S
DOI 10.1042/bst023584s, PubMed 8654769
Comparative genomic hybridization analysis of human sarcomas: II. Identification of novel amplicons at 6p and 17p in osteosarcomas
Genes Chromosomes Cancer, 14 (1), 15-21
DOI 10.1002/gcc.2870140104, PubMed 8527379
Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas
Genes Chromosomes Cancer, 14 (1), 8-14
DOI 10.1002/gcc.2870140103, PubMed 8527390
Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1
Br J Cancer, 72 (2), 393-8
DOI 10.1038/bjc.1995.344, PubMed 7640224
In vitro and in vivo variation in transferrin receptor expression on a human medulloblastoma cell line
Neurosurgery, 36 (6), 1158-63; discussion 1163-4
DOI 10.1227/00006123-199506000-00015, PubMed 7643997
Accumulation of p53 protein in human malignant melanoma. Relationship to clinical outcome
Melanoma Res, 5 (3), 183-7
DOI 10.1097/00008390-199506000-00007, PubMed 7640520
Endocrine and metabolic characteristics of polyoma large T transgenic mice that develop ACTH-producing pituitary tumors
J Neurosurg, 82 (5), 879-85
DOI 10.3171/jns.1995.82.5.0879, PubMed 7714615
Semiquantitative polymerase chain reaction for t(14;18) in follicular lymphomas: a colorimetric approach
Lab Invest, 72 (4), 411-8
PubMed 7723279
An Effective, Direct Immunomagnetic Procedure for Purging Acute Lymphoblastic Leukemia Cells from Human Bone Marrow
Pathol Oncol Res, 1 (1), 32-37
DOI 10.1007/BF02893581, PubMed 11173565
The protooncogene CHOP/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomas
Cancer Genet Cytogenet, 78 (2), 165-71
DOI 10.1016/0165-4608(94)90085-x, PubMed 7828148
MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status
J Natl Cancer Inst, 86 (17), 1297-302
DOI 10.1093/jnci/86.17.1297, PubMed 8064888
Microenvironment revisited: time for reappraisal of some prevailing concepts of cancer metastasis
J Cell Biochem, 56 (1), 23-8
DOI 10.1002/jcb.240560106, PubMed 7806588
Helix pomatia agglutinin binding in human tumour cell lines: correlation with pulmonary metastases in nude mice
Br J Cancer, 69 (6), 1021-4
DOI 10.1038/bjc.1994.200, PubMed 8198963
Preclinical phase II studies in human tumor xenografts: a European multicenter follow-up study
Ann Oncol, 5 (5), 415-22
DOI 10.1093/oxfordjournals.annonc.a058872, PubMed 8075048
Targeted therapy with immunotoxins in a nude rat model for leptomeningeal growth of human small cell lung cancer
Cancer Res, 54 (8), 2146-50
PubMed 8174121
Validity and usefulness of human tumor models established by intratibial cell inoculation in nude rats
Cancer Res, 54 (7), 1715-9
PubMed 8137286
In vivo efficacy of intrathecal transferrin-Pseudomonas exotoxin A immunotoxin against LOX melanoma
Neurosurgery, 34 (4), 649-55; discussion 655-6
DOI 10.1227/00006123-199404000-00012, PubMed 8008162
TP53 allele loss, mutations and expression in malignant melanoma
Br J Cancer, 69 (2), 253-9
DOI 10.1038/bjc.1994.48, PubMed 7905277
Comparison of two antibody-based methods for elimination of breast cancer cells from human bone marrow
Cancer Res, 54 (1), 209-14
PubMed 7505198
Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines
Anticancer Res, 14 (6B), 2445-51
PubMed 7872665
Nude rat models for human tumor metastasis to CNS. Procedures for intracarotid delivery of cancer cells and drugs
J Neurooncol, 21 (3), 215-24
DOI 10.1007/BF01063770, PubMed 7699416
A direct and effective immunomagnetic method for bone marrow purging in non-T ALL malignancies. The use of an anti-HLA-DR antibody gives sustained engraftment
Prog Clin Biol Res, 389, 119-24
PubMed 7700893
Immunoscintigraphy of bone sarcomas--results in 5 patients
Eur J Cancer, 30A (10), 1484-9
DOI 10.1016/0959-8049(94)00304-n, PubMed 7833107
Autologous bone marrow transplantation of non-Hodgkin's lymphoma patients with marrow purged using immunomagnetic beads
Prog Clin Biol Res, 389, 133-8
PubMed 7700895
Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2
Cell Growth Differ, 4 (12), 1065-70
PubMed 8117620
Rapid detection of transferrin receptor expression on glioma cell lines by using magnetic microspheres
Neurosurgery, 33 (5), 878-81
DOI 10.1227/00006123-199311000-00015, PubMed 8264887
Eradication of small cell lung cancer cells from human bone marrow with immunotoxins
Cancer Res, 53 (16), 3784-8
PubMed 8393381
Effective removal of SCLC cells from human bone marrow. Use of four monoclonal antibodies and immunomagnetic beads
Br J Cancer, 67 (6), 1331-6
DOI 10.1038/bjc.1993.246, PubMed 8390285
[Transgenic mice as animal model of Cushing's syndrome]
Tidsskr Nor Laegeforen, 113 (2), 206-10
PubMed 8381565
METASTATIC ABILITY OF CANCER-CELLS - PHENOTYPIC AND GENOTYPIC CHARACTERISTICS AND ROLE OF THE MICROENVIRONMENT
NEW FRONTIERS IN CANCER CAUSATION, 349-358
Monoclonal antibody accumulation in experimental and spontaneous lung metastases of human malignant melanoma in rodents
J Cancer Res Clin Oncol, 119 (6), 342-5
DOI 10.1007/BF01208842, PubMed 8449971
CHROMOSOME-17P ABERRATIONS AND P53 EXPRESSION IN HUMAN SARCOMAS
FRONTIERS OF OSTEOSARCOMA RESEARCH: INTERDISCIPLINARY SURVEY OF CLINICAL AND RESEARCH ADVANCES, 419-422
Preclinical antitumour activity and animal toxicology studies of rhizoxin, a novel tubulin-interacting agent
Ann Oncol, 3 (9), 755-63
DOI 10.1093/oxfordjournals.annonc.a058334, PubMed 1450065
A STUDY OF THE DELIVERY-TARGETING CONCEPT APPLIED TO ANTINEOPLASTIC DRUGS ACTIVE ON HUMAN OSTEOSARCOMA .1. SYNTHESIS AND BIOLOGICAL-ACTIVITY IN NUDE-MICE CARRYING HUMAN OSTEOSARCOMA XENOGRAFTS OF GEM-BISPHOSPHONIC METHOTREXATE ANALOGS
Eur. J. Med. Chem., 27 (8), 825-833
DOI 10.1016/0223-5234(92)90117-J
Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative study
Cancer Res, 52 (21), 5940-7
PubMed 1394220
Immunotoxins directed against the high-molecular-weight melanoma-associated antigen. Identification of potent antibody-toxin combinations
Int J Cancer, 52 (4), 631-5
DOI 10.1002/ijc.2910520423, PubMed 1399146
An effective immunomagnetic method for bone marrow purging in T cell malignancies
Bone Marrow Transplant, 9 (5), 319-23
PubMed 1617315
In vitro efficacy of transferrin-toxin conjugates against glioblastoma multiforme
J Neurosurg, 76 (5), 838-44
DOI 10.3171/jns.1992.76.5.0838, PubMed 1314294
Site-dependent differences in sensitivity of LOX human melanoma tumors in nude rats to dacarbazine and mitozolomide, but not to doxorubicin and cisplatin
Cancer Res, 52 (5), 1347-51
PubMed 1737396
Comparative antitumour activity of vinblastine-isoleucinate and related vinca alkaloids in human tumour xenografts
Eur J Cancer, 28A (4-5), 767-73
DOI 10.1016/0959-8049(92)90112-f, PubMed 1524896
Chromosome 13 alterations in osteosarcoma cell lines derived from a patient with previous retinoblastoma
Cancer Genet Cytogenet, 57 (1), 31-40
DOI 10.1016/0165-4608(91)90186-x, PubMed 1684533
Different metastasis patterns of a human melanoma cell line in nude mice and rats: influence of microenvironment
J Natl Cancer Inst, 83 (14), 1020-4
DOI 10.1093/jnci/83.14.1020, PubMed 2072409
Practical spontaneous metastasis model for in vivo therapeutic studies using a human melanoma
Cancer Res, 51 (11), 2837-41
PubMed 2032224
SELECTION OF ANTI-SCLC ANTIBODIES FOR DIAGNOSIS OF BONE-MARROW METASTASIS
Br. J. Cancer, 63 14, 49-53
Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis
Br J Cancer Suppl, 14, 49-53
PubMed 1645572
Athymic rats in preclinical immunodiagnostic studies
Anticancer Res, 11 (2), 649-55
PubMed 2064318
A human tumor lung metastasis model in athymic nude rats
Cancer Res, 49 (18), 5148-52
PubMed 2766284
Immunomagnetic removal of B-lymphoma cells using a novel mono-sized magnetizable polymer bead, M-280, in conjunction with primary IgM and IgG antibodies
Bone Marrow Transplant, 4 (5), 567-74
PubMed 2790334
Antibodies detecting abnormalities of the retinoblastoma susceptibility gene product (pp110RB) in osteosarcomas and synovial sarcomas
Oncogene Res, 4 (3), 205-14
PubMed 2740144
Successful clinical use of an anti-HLA-DR monoclonal antibody for autologous bone marrow transplantation
J Natl Cancer Inst, 80 (16), 1322-5
DOI 10.1093/jnci/80.16.1322, PubMed 3050139
Kinetics of uptake and degradation of an abrin immunotoxin by melanoma cells and studies of the rates of cellular intoxication
Int J Cancer, 42 (3), 400-4
DOI 10.1002/ijc.2910420316, PubMed 3262091
Expression and characteristics of a novel human osteosarcoma-associated cell surface antigen
Cancer Res, 48 (18), 5302-9
PubMed 2457439
Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cells
Cancer Res, 48 (15), 4382-8
PubMed 3390834
A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX
Int J Cancer, 41 (3), 442-9
DOI 10.1002/ijc.2910410322, PubMed 3346110
Preclinical phase II studies in human tumor lines: a European multicenter study
Eur J Cancer Clin Oncol, 24 (3), 567-73
DOI 10.1016/s0277-5379(98)90039-6, PubMed 3383962
Sodium thiosulfate fails to increase the therapeutic index of intravenously administered cis-diamminedichloroplatinum (II) in mice bearing murine and human tumors
Cancer Chemother Pharmacol, 21 (2), 129-33
DOI 10.1007/BF00257358, PubMed 3349560
IMMUNOMAGNETIC PURGING OF BETA-LYMPHOMA CELLS FROM BONE-MARROW
Bone Marrow Transplant., 3 1, 97
Immunomagnetic removal of B-lymphoma cells from human bone marrow: a procedure for clinical use
Bone Marrow Transplant, 3 (1), 31-41
PubMed 3048468
Some procedures to reduce cis-platinum toxicity reduce antitumour activity
Cancer Treat Rev, 14 (3-4), 389-95
DOI 10.1016/0305-7372(87)90035-1, PubMed 3326670
Studies on the mechanism of action of abrin-9.2.27 immunotoxin in human melanoma cell lines
Cancer Res, 47 (23), 6243-7
PubMed 2445469
Selective localisation of two radiolabelled anti-sarcoma monoclonal antibodies in human osteosarcoma xenografts
Br J Cancer, 56 (1), 21-5
DOI 10.1038/bjc.1987.146, PubMed 3476143
Mitozolomide (NSC 353451), a new active drug in the treatment of malignant melanoma. Phase II trial in patients with advanced disease
Br J Cancer, 55 (4), 433-5
DOI 10.1038/bjc.1987.85, PubMed 3580266
Chromosome 13 instability and esterase D expression in an osteosarcoma cell line
Cancer Genet Cytogenet, 24 (2), 327-34
DOI 10.1016/0165-4608(87)90115-4, PubMed 2878716
Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies
Cancer Res, 47 (3), 846-51
PubMed 3492268
Metastasis models for human tumors in athymic mice: useful models for drug development
Cancer Detect Prev Suppl, 1, 291-9
PubMed 3480056
Human melanoma cell lines showing striking inherent differences in sensitivity to immunotoxins containing holotoxins
J Natl Cancer Inst, 77 (6), 1247-53
PubMed 3491924
New monoclonal antibodies specific for human sarcomas
Int J Cancer, 38 (1), 27-31
DOI 10.1002/ijc.2910380106, PubMed 3522438
Characteristics of a cell line established from a patient with multiple osteosarcoma, appearing 13 years after treatment for bilateral retinoblastoma
Int J Cancer, 38 (1), 33-40
DOI 10.1002/ijc.2910380107, PubMed 3459716
Chemosensitivity profiles of human cancers assessed by the 6-day SRC assay on serially xenografted tumors
Int J Cancer, 37 (4), 579-87
DOI 10.1002/ijc.2910370417, PubMed 3957463
Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition
Proc Natl Acad Sci U S A, 82 (18), 6216-20
DOI 10.1073/pnas.82.18.6216, PubMed 2994066
Radiolocalization of xenografted human malignant melanoma by a monoclonal antibody (9.2.27) to a melanoma-associated antigen in nude mice
Cancer Res, 45 (9), 4150-5
PubMed 4028007
The use of multicellular spheroids in establishing human sarcoma cell lines in vitro
Int J Cancer, 35 (6), 793-8
DOI 10.1002/ijc.2910350616, PubMed 2409034
Activity of mitozolomide (NSC 353451), a new imidazotetrazine, against xenografts from human melanomas, sarcomas, and lung and colon carcinomas
Cancer Res, 45 (4), 1778-86
PubMed 3978640
Characteristics of human tumour xenografts transplanted under the renal capsule of immunocompetent mice
Br J Cancer, 51 (3), 347-56
DOI 10.1038/bjc.1985.46, PubMed 3970811
The six-day subrenal capsule assay (SRCA) for testing the response of human tumours to anticancer agents. Validity and usefulness in cancer research and treatment
Ann Chir Gynaecol Suppl, 199, 51-9
PubMed 3864392
Intra-arterial infusion of mitomycin C in treatment of breast cancer: occurrence of skin necrosis in irradiated patients
Radiother Oncol, 4 (2), 127-32
DOI 10.1016/s0167-8140(85)80099-2, PubMed 3934716
THE 6-DAY SUBRENAL CAPSULE ASSAY (SRCA) FOR TESTING THE RESPONSE OF HUMAN-TUMORS TO ANTICANCER AGENTS - VALIDITY AND USEFULNESS IN CANCER-RESEARCH AND TREATMENT
Ann. Chir. Gynaecol., 74 199, 51-59
Methodological aspects of the 6-day subrenal capsule assay for measuring the response of human tumors to anticancer agents
Anticancer Res, 5 (4), 329-37
PubMed 4037730
Human tumor xenografts transplanted under the renal capsule of conventional mice. Growth rates and host immune response
Int J Cancer, 34 (5), 725-30
DOI 10.1002/ijc.2910340521, PubMed 6500747
Stable quantitative differences of antigen expression in human melanoma cells isolated by flow cytometric cell sorting
Int J Cancer, 34 (4), 507-12
DOI 10.1002/ijc.2910340413, PubMed 6386700
Lack of correlation between natural killer activity and tumor growth control in nude mice with different immune defects
Cancer Res, 44 (10), 4403-8
PubMed 6467201
Reduced antineoplastic activity in mice of cisplatin administered with high salt concentration in the vehicle
J Natl Cancer Inst, 73 (3), 743-52
PubMed 6590919
Immune characteristics of the beige-nude mouse. A model for studying immune surveillance
Scand J Immunol, 20 (3), 267-72
DOI 10.1111/j.1365-3083.1984.tb01002.x, PubMed 6494809
Antigen expression in human melanoma cells in relation to growth conditions and cell-cycle distribution
Int J Cancer, 33 (2), 167-71
DOI 10.1002/ijc.2910330203, PubMed 6693198
Phase I study of the plant protein ricin
Cancer Res, 44 (2), 862-5
PubMed 6692385
Pharmacological studies of ricin in mice and humans
Cancer Chemother Pharmacol, 13 (3), 157-63
DOI 10.1007/BF00269021, PubMed 6488437
Antibody formation against the cytotoxic proteins abrin and ricin in humans and mice
Int J Cancer, 32 (4), 515-21
DOI 10.1002/ijc.2910320420, PubMed 6618711
Growth characteristics of human melanoma xenografts
Cell Tissue Kinet, 15 (5), 545-54
DOI 10.1111/j.1365-2184.1982.tb01576.x, PubMed 7127402
Synergistic effect of ricin in combination with daunorubicin, cis-dichlorodiammineplatinum(II) and vincristine in systemic L1210 leukemia
Cancer Res, 42 (6), 2152-8
PubMed 7200398
Colony growth and chemosensitivity in vitro of human melanoma biopsies. Relationship to clinical parameters
Int J Cancer, 29 (5), 533-8
DOI 10.1002/ijc.2910290508, PubMed 7095899
The usefulness of human tumor cell lines in the study of chemosensitivity. A study of malignant melanomas
Int J Cancer, 28 (4), 403-8
DOI 10.1002/ijc.2910280402, PubMed 7309286
Comparison of two soft-agar methods for assaying chemosensitivity of human tumours in vitro: malignant melanomas
Br J Cancer, 44 (4), 539-44
DOI 10.1038/bjc.1981.223, PubMed 7295510
Cultivation of human melanomas in soft agar. Factors influencing plating efficiency and chemosensitivity
Int J Cancer, 28 (3), 329-34
DOI 10.1002/ijc.2910280312, PubMed 7319675
In vitro sensitivity of human melanoma xenografts to cytotoxic drugs. Correlation with in vivo chemosensitivity
Int J Cancer, 26 (6), 717-22
DOI 10.1002/ijc.2910260604, PubMed 7216540
Synergistic effect of adriamycin and ricin on L1210 leukemic cells in mice
Cancer Res, 40 (10), 3735-9
PubMed 7438056
A human melanoma cell line established from xenograft in athymic mice
Br J Cancer, 41 (5), 724-33
DOI 10.1038/bjc.1980.134, PubMed 7426299
Response to chemotherapy of human, malignant melanoma xenografts in athymic, nude mice
Int J Cancer, 25 (4), 453-8
DOI 10.1002/ijc.2910250405, PubMed 7372371
Assessment of tumour growth and of response to chemotherapy of human melanomas in athymic, nude mice
Br J Cancer Suppl, 4, 146-9
PubMed 6932918
Human embryonal carcinoma grown in athymic mice and in vitro
Cancer Res, 40 (3), 949-53
PubMed 7471109
ASSESSMENT OF TUMOR-GROWTH AND OF RESPONSE TO CHEMOTHERAPY OF HUMAN MELANOMAS IN ATHYMIC, NUDE-MICE
Br. J. Cancer, 41 4, 146-149
Toxicity of abrin and ricin in mice and dogs
J Toxicol Environ Health, 5 (6), 1073-84
DOI 10.1080/15287397909529815, PubMed 529341
Treatment of micrometastases from Lewis lung carcinoma with abrin and cyclophosphamide, given singly and in combination
Int J Cancer, 23 (4), 530-5
DOI 10.1002/ijc.2910230414, PubMed 437927
Human gastrointestinal cancer grown in nude mice used to test new chemotherapeutic agents
Front Gastrointest Res, 5, 71-80
DOI 10.1159/000402313, PubMed 91567
Effect of ricin and abrin on survival of L1210 leukemic mice and on leukemic and normal bone-marrow cells
Int J Cancer, 22 (5), 558-63
DOI 10.1002/ijc.2910220509, PubMed 721316
Inhibitory effect of abrin and ricin on the growth of transplantable murine tumors and of abrin on human cancers in nude mice
Cancer Res, 37 (12), 4559-67
PubMed 922739
Studies on the accessability of ribosomes to inactivation by the toxic lectins abrin and ricin
Eur J Biochem, 74 (2), 209-15
DOI 10.1111/j.1432-1033.1977.tb11383.x, PubMed 856578
Toxicity, distribution and elimination of the cancerostatic lectins abrin and ricin after parenteral injection into mice
Br J Cancer, 34 (4), 418-25
DOI 10.1038/bjc.1976.187, PubMed 974006
Review articles
New frontiers in immune checkpoint B7-H3 (CD276) research and drug development
Mol Cancer, 22 (1), 43
DOI 10.1186/s12943-023-01751-9, PubMed 36859240
B7-H3 Immune Checkpoint Protein in Human Cancer
Curr Med Chem, 27 (24), 4062-4086
DOI 10.2174/0929867326666190517115515, PubMed 31099317
Interplay between Immune Checkpoint Proteins and Cellular Metabolism
Cancer Res, 77 (6), 1245-1249
DOI 10.1158/0008-5472.CAN-16-1647, PubMed 28246276
B7-H3 and its relevance in cancer; immunological and non-immunological perspectives
Front Biosci (Elite Ed), 3 (3), 989-93
DOI 10.2741/e304, PubMed 21622107
MicroRNAs as biomarkers in colorectal cancer
Am J Pathol, 177 (4), 1592-9
DOI 10.2353/ajpath.2010.100024, PubMed 20829435
Epigenetics in human melanoma
Cancer Control, 16 (3), 200-18
DOI 10.1177/107327480901600302, PubMed 19556960
Emerging role of nuclear protein 1 (NUPR1) in cancer biology
Cancer Metastasis Rev, 28 (1-2), 225-32
DOI 10.1007/s10555-009-9183-x, PubMed 19153668
The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion
Curr Cancer Drug Targets, 8 (5), 404-13
DOI 10.2174/156800908785133141, PubMed 18690846
NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress
Curr Cancer Drug Targets, 8 (5), 421-30
DOI 10.2174/156800908785133196, PubMed 18690848
Detection and clinical importance of micrometastatic disease
J Natl Cancer Inst, 91 (13), 1113-24
DOI 10.1093/jnci/91.13.1113, PubMed 10393719
Purging of tumor cells from leukapheresis products: experimental and clinical aspects
J Hematother, 5 (4), 427-36
DOI 10.1089/scd.1.1996.5.427, PubMed 8877718
Immunotoxins and central nervous system neoplasia
J Neurosurg, 76 (1), 1-12
DOI 10.3171/jns.1992.76.1.0001, PubMed 1727147
Other articles
Author Correction: The expression pattern of pyruvate dehydrogenase kinases predicts prognosis and correlates with immune exhaustion in clear cell renal cell carcinoma
Sci Rep, 13 (1), 9186
DOI 10.1038/s41598-023-36328-5, PubMed 37280349
B7-H3 in Cancer - Beyond Immune Regulation
Trends Cancer, 4 (6), 401-404
DOI 10.1016/j.trecan.2018.03.010, PubMed 29860983
Human malignant melanoma harbours a large fraction of highly clonogenic cells that do not express markers associated with cancer stem cells
Pigment Cell Melanoma Res, 23 (3), 449-51
DOI 10.1111/j.1755-148X.2010.00690.x, PubMed 20236249
[Prostate-specific membrane antigen]
Tidsskr Nor Laegeforen, 116 (3), 411-2
PubMed 8638273
Pronounced therapeutic effect of samarium 153-ethylenediaminetetramethylene phosphonate in an orthotopic human osteosarcoma tibial tumor model
J Natl Cancer Inst, 87 (3), 221-2
DOI 10.1093/jnci/87.3.221, PubMed 7707409
Suppression of the neoplastic phenotype in vivo by an anti-ras ribozyme
Cancer Res, 54 (4), 900-2
PubMed 8313379
Expression of the neuroectodermal intermediate filament nestin in human melanomas
Cancer Res, 54 (2), 354-6
PubMed 8275467
Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression
Cancer Res, 52 (21), 6088-91
PubMed 1356624
Detection of bone marrow metastases in small cell lung cancer patients. Comparison of immunologic and morphologic methods
Am J Pathol, 141 (3), 531-8
PubMed 1381558
Tumorigenicity and dissemination of human tumors in congenitally immune-deficient mice
J Natl Cancer Inst, 83 (19), 1419-20
DOI 10.1093/jnci/83.19.1419, PubMed 1920486
EXPERIMENTAL BONE AND BONE-MARROW METASTASIS IN LABORATORY-ANIMALS - RESPONSE
J. Natl. Cancer Inst., 82 (12), 1070
DOI 10.1093/jnci/82.12.1070
Nude rat model for studying metastasis of human tumor cells to bone and bone marrow
J Natl Cancer Inst, 82 (5), 408-12
DOI 10.1093/jnci/82.5.408, PubMed 2304088
New indirect approach to the therapeutic use of immunotoxins
J Natl Cancer Inst, 80 (6), 439-43
DOI 10.1093/jnci/80.6.439, PubMed 3259265
Unexpected expression of the 250 kD melanoma-associated antigen in human sarcoma cells
Br J Cancer, 53 (6), 839-41
DOI 10.1038/bjc.1986.142, PubMed 3718838
Spherical bodies
Ultrastruct Pathol, 7 (1), 73-8
DOI 10.3109/01913128409141857, PubMed 6097001
Spontaneous alteration in growth rates of two human melanoma xenografts. Concurrent changes in chemosensitivity
Eur J Cancer Clin Oncol, 19 (8), 1175-8
DOI 10.1016/0277-5379(83)90046-9, PubMed 6684563
An inverse relationship between the growth rate of human melanoma xenografts and their response to some cytostatic drugs
Br J Cancer, 41 (5), 829-31
DOI 10.1038/bjc.1980.149, PubMed 7426308
Doxorubicin and ricin, a strongly synergistic combination in mouse leukemia
Cancer Treat Rep, 64 (12), 1375-8
PubMed 7471125
Books
Metastasis of breast cancer
Springer, Dordrecht, XIV, 435 s.
BIBSYS 070516383, ISBN 978-1-4020-5866-0
Theses
Preclinical studies of the cancerostatic lectins abrin and ricin: toxicity and effect on murine tumors and on human tumor xenografts in athymic, nude mice
[Forfatteren], Oslo, 1 b. (fl.pag.)
BIBSYS 812138147